Marshall Wace, LLP Staar Surgical CO Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Staar Surgical CO stock. As of the latest transaction made, Marshall Wace, LLP holds 152,553 shares of STAA stock, worth $2.67 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
152,553
Previous 344,576
55.73%
Holding current value
$2.67 Million
Previous $12.8 Million
71.05%
% of portfolio
0.0%
Previous 0.02%
Shares
19 transactions
Others Institutions Holding STAA
# of Institutions
233Shares Held
47.7MCall Options Held
98.6KPut Options Held
180K-
Broadwood Capital Inc New York, NY10.8MShares$190 Million20.84% of portfolio
-
Black Rock Inc. New York, NY7.49MShares$131 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.86MShares$102 Million0.0% of portfolio
-
State Street Corp Boston, MA2.05MShares$35.9 Million0.0% of portfolio
-
Resona Asset Management Co.,Ltd. Koto Ku,Tokyo, M01.5MShares$26.3 Million0.22% of portfolio
About STAAR SURGICAL CO
- Ticker STAA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 48,038,300
- Market Cap $841M
- Description
- STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...